Related Experiment Video
Updated: Apr 24, 2026

06:00
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
10.8K
Beclin-1 and its role as a target for anticancer therapy
1Department of Clinical Chemistry and Molecular Diagnostics, Poznan University of Medical Sciences, Poznan, Poland. mrybczyn@ump.edu.pl.
Summary
Autophagy, a cellular recycling process, is regulated by the Beclin-1 protein. Beclin-1
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Cell death is classified into types like necrosis, apoptosis, autophagy, and cornification.
- Autophagy (macroautophagy) is a conserved process for degrading cellular components and recycling materials.
- Beclin-1 is a key protein regulating autophagy initiation and progression.
Purpose of the Study:
- To review recent advances in understanding autophagy's molecular dynamics and regulation.
- To discuss the role of Beclin-1 in the autophagy pathway.
- To explore Beclin-1's potential contribution to anticancer therapy.
Main Methods:
- Literature review of recent research on autophagy and Beclin-1.
- Analysis of Beclin-1's interactions with cofactors and its role in complex formation.
- Discussion of the correlation between Beclin-1 expression/activity and carcinogenesis.
Main Results:
- Beclin-1 interacts with multiple cofactors to form a critical complex that initiates autophagy.
- Beclin-1 dysfunction is linked to various diseases, including cancer.
- Evidence suggests a dual role for Beclin-1 in carcinogenesis.
Conclusions:
- Beclin-1 is central to the regulation of autophagy.
- Understanding Beclin-1's role is crucial for developing new therapeutic strategies, particularly in cancer.
- Further research into Beclin-1's molecular dynamics can advance autophagy-related disease treatments.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies
1.4K
1.4K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
The Intrinsic Apoptotic Pathway
6.1K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.1K

